Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Download PDF
Thromb Haemost 2013; 110(03): 396-398
DOI: 10.1160/TH13-07-0583
DOI: 10.1160/TH13-07-0583
Theme Issue Editorial
The kallikreins: old proteases with new clinical potentials
Further Information
Publication History
Received:
19 July 2013
Accepted:
19 July 2013
Publication Date:
22 November 2017 (online)
-
References
- 1 Schmitt M, Magdolen V. Using kallikrein-related peptidases (KLK) as novel cancer biomarkers. Thromb Haemost 2009; 101: 222-224.
- 2 Borgono CA, Diamandis EP. The emerging roles of human tissue kallikreins in cancer. Nat Rev Cancer 2004; 04: 876-890.
- 3 Clements JA. Reflections on the tissue kallikrein and kallikrein-related peptidase family - from mice to men - what have we learnt in the last two decades?. Biol Chem 2008; 389: 1447-1454.
- 4 Kontos CK, Scorilas A. Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers. Clin Chem Lab Med 2012; 50: 1877-1891.
- 5 Lundwall A. Old genes and new genes: The evolution of the kallikrein locus. Thromb Haemost 2013; 110: 469-475.
- 6 Vickers AJ, Roobol MJ, Lilja H. Screening for prostate cancer: early detection or overdetection?. Annu Rev Med 2012; 63: 161-170.
- 7 Shaw JL, Diamandis EP. Distribution of 15 human kallikreins in tissues and biological fluids. Clin Chem 2007; 53: 1423-1432.
- 8 Pathak M, Wong SS, Dreveny I. et al. Structure of plasma and tissue kallikreins. Thromb Haemost 2013; 110: 423-433.
- 9 Ekholm IE, Brattsand M, Egelrud T. Stratum corneum tryptic enzyme in normal epidermis: a missing link in the desquamation process?. J Invest Dermatol 2000; 114: 56-63.
- 10 Fischer J, Meyer-Hoffert U. Regulation of kallikrein-related peptidases in the skin - from physiology to diseases to therapeutic options. Thromb Haemost 2013; 110: 442-449.
- 11 Sotiropoulou G, Pampalakis G. Targeting the kallikrein-related peptidases for drug development. Trends Pharmacol Sci 2012; 33: 623-634.
- 12 Kontos CK, Mavridis K, Talieri M. et al. Kallikrein-related peptidases (KLKs) in gastrointestinal cancer: Mechanistic and clinical aspects. Thromb Haemost 2013; 110: 450-457.
- 13 Dorn J, Bayani J, Yousef GM. et al. Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies. Thromb Haemost 2013; 110: 408-422.
- 14 Thorek DLJ, Evans MJ, Carlsson SV. et al. Prostate specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Thromb Haemost 2013; 110: 484-492.
- 15 Waeckel L, Potier L, Richer C. et al. Pathophysiology of genetic deficiency in tissue kallikrein activity in mouse and man. Thromb Haemost 2013; 110: 476-483.
- 16 Fink E, Bhoola KD, Snyman C. et al. Cellular expression of plasma prekallikrein in human tissues. Biol Chem 2007; 388: 957-963.
- 17 Marcondes S, Antunes E. The plasma and tissue kininogen-kallikrein-kinin system: role in the cardiovascular system. Curr Med Chem Cardiovasc Hematol Agents 2005; 03: 33-44.
- 18 Björkqvist J, Jämsä A, Renné T. Plasma kallikrein: the bradykinin-producing enzyme. Thromb Haemost 2013; 110: 399-407.
- 19 Feener EP, Zhou Q, Fickweiler W. Role of plasma kallikrein in diabetes and metabolism. Thromb Haemost 2013; 110: 434-441.
- 20 Pruneau D, Belichard P, Sahel JA. et al. Targeting the kallikrein-kinin system as a new therapeutic approach to diabetic retinopathy. Curr Opin Investig Drugs 2010; 11: 507-514.
- 21 de Maat S, van Dooremalen S, de Groot PG. et al. A nanobody-based method for tracking factor XII activation in plasma. Thromb Haemost 2013; 110: 458-468.